More and more people worldwide suffer from degenerative diseases like osteoporosis and osteoarthritis. The need for effective therapies is increasing rapidly. New hope for patients comes from innovative German high-tech medical devices that will be available on the Asian continent in future. At Asia Health Exhibition 2017 MedTec Medizintechnik GmbH will present its newest therapy device.

New demands on global healthcare

The ageing population and rising number of patients suffering from chronic diseases pose a serious obligation to healthcare systems. Degenerative diseases like osteoarthritis or osteoporosis are a global health problem – with high costs for the health system, the economy, resulting from the incapacity to work, and especially for the patients suffering pains and serious interference in their daily lives from restrictions on movement. Medical opportunities fall short to fulfill the need for effective therapies. Innovative approaches for treatment are needed.

State of the art medical technology for the treatment of degenerative diseases of the musculosceletal systemAt Asia Health Exhibition in Singapore in April new ways to cope with the various rising demands of healthcare will be presented. One of the international exhibitors is the German company MedTec Medizintechnik GmbH who has repeatedly been awarded as one of Germany’s most innovative SMEs. MedTec develops and produces high-tech medical technology for the treatment of degenerative diseases of the musculoskeletal system.

MBST – Nuclear Magnetic Resonance Therapy

MBST uses nuclear magnetic resonance technology in a development of the worldwide known top standard in medical imaging, MRI. The MBST therapy sequences direct energy in a targeted manner into specific cells. This energy transfer can reactivate disturbed regeneration processes and the body’s self-repair mechanisms. Over 260,000 patients have been treated in Germany alone. Various medical studies and publications as well as the experience of over 15 years in clinical usage testify to the active principle.

Exclusive presentation of newest generation of therapy devicesThe patented therapy system combines scientifically proven knowledge and technological expertise with the power of medical innovation and makes MedTec Medizintechnik GmbH world market leader in the field of magnetic resonance technology used for therapeutic purposes. The newly developed ARTHRO·SPIN·FLEX system components are a milestone in nuclear magnetic resonance technology. The aim of MBST therapy is the reliable, gentle and safe treatment of a variety of degenerative diseases of the muscular and skeletal system and for bone metabolism disorders.MedTec / MBST at Asia Health Exhibition 2017 in Singapore: 3–5 April, stand number R16.

About MedTec Medizintechnik GmbH

Over the last two decades, the MedTec brand has stood for technical progress, innovation and quality in medical technology. MedTec Medizintechnik GmbH has been developing and producing state of the art medical technology in Wetzlar. Research, Development and Production · Made in Germany. With its patented therapy system MedTec Medizintechnik GmbH is world market leader in the field of magnetic resonance technology used for therapeutic purposes. MBST therapy is used successfully in 39 countries worldwide. A huge number of scientific and clinical studies and convincing therapy results with over 260,000 treated patients testify to the active principle of the innovative therapy system. MBST provides gentle and effective treatment of degenerative diseases of the musculosceletal system without side-effects. In 2016, MedTec Medizintechnik GmbH was awarded for the second time as top innovator and one of Germany’s top 100 of the most innovative medium-sized companies.

For more information visit: www.mbst.de